B ALL
Clinical trials for B ALL explained in plain language.
Never miss a new study
Get alerted when new B ALL trials appear
Sign up with your email to follow new studies for B ALL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy aims to tackle tough leukemia
Disease control Not yet recruitingThis study tests whether combining two drugs, inotuzumab and blinatumomab, is safe and works well for adults newly diagnosed with B-cell acute lymphoblastic leukemia (B-ALL). It includes people aged 18 and older who cannot have standard chemotherapy. The goal is to see if the tre…
Matched conditions: B ALL
Phase: PHASE1, PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 22, 2026 12:07 UTC
-
Engineered immune cells take aim at Hard-to-Treat leukemia
Disease control Not yet recruitingThis early-phase trial tests a new treatment called TSLPR-CART for adults with B-cell acute lymphoblastic leukemia (B-ALL) that has come back or not responded to standard therapy. The treatment uses a patient's own immune cells, modified in a lab to recognize and attack cancer ce…
Matched conditions: B ALL
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 10, 2026 13:26 UTC